Taho Pharmaceuticals Ltd. (TPEX:6467)

Taho Pharmaceuticals Revenue

Taho Pharmaceuticals had revenue of 1.34M TWD in the quarter ending June 30, 2026, a decrease of -71.95%. This brings the company's revenue in the last twelve months to 1.98M, down -74.53% year-over-year. In the year 2025, Taho Pharmaceuticals had annual revenue of 8.41M.

• Revenue (ttm): 1.98M
• Revenue Growth: -74.53%
• P/S Ratio: 4,709.05
• Revenue / Employee: 56.60K
• Employees: 35
• Market Cap: 9.33B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.41M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	1.07M	-5.29M	-83.23%
Dec 31, 2022	6.36M	-6.04M	-48.73%
Dec 31, 2017	12.40M	-23.61M	-65.57%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error